Lohr JB - Search Results

1

Oxidative mechanisms and tardive dyskinesia.

Lohr JB, Kuczenski R, Niculescu AB. Lohr JB, et al. CNS Drugs. 2003;17(1):47-62. doi: 10.2165/00023210-200317010-00004. CNS Drugs. 2003. PMID: 12467492 Review.

2

Handwriting movement analyses for monitoring drug-induced motor side effects in schizophrenia patients treated with risperidone.

Caligiuri MP, Teulings HL, Dean CE, Niculescu AB, Lohr J. Caligiuri MP, et al. Hum Mov Sci. 2009 Oct;28(5):633-42. doi: 10.1016/j.humov.2009.07.007. Epub 2009 Aug 18. Hum Mov Sci. 2009. PMID: 19692133 Free PMC article.

3

Handwriting movement kinematics for quantifying extrapyramidal side effects in patients treated with atypical antipsychotics.

Caligiuri MP, Teulings HL, Dean CE, Niculescu AB 3rd, Lohr JB. Caligiuri MP, et al. Among authors: lohr jb. Psychiatry Res. 2010 May 15;177(1-2):77-83. doi: 10.1016/j.psychres.2009.07.005. Epub 2010 Apr 9. Psychiatry Res. 2010. PMID: 20381875 Free PMC article.

4

Increased indices of free radical activity in the cerebrospinal fluid of patients with tardive dyskinesia.

Lohr JB, Kuczenski R, Bracha HS, Moir M, Jeste DV. Lohr JB, et al. Biol Psychiatry. 1990 Sep 15;28(6):535-9. doi: 10.1016/0006-3223(90)90490-s. Biol Psychiatry. 1990. PMID: 1699612 No abstract available.

5

Candidate genes, pathways and mechanisms for bipolar (manic-depressive) and related disorders: an expanded convergent functional genomics approach.

Ogden CA, Rich ME, Schork NJ, Paulus MP, Geyer MA, Lohr JB, Kuczenski R, Niculescu AB. Ogden CA, et al. Among authors: lohr jb. Mol Psychiatry. 2004 Nov;9(11):1007-29. doi: 10.1038/sj.mp.4001547. Mol Psychiatry. 2004. PMID: 15314610

6

Striatopallidal regulation of affect in bipolar disorder.

Caligiuri MP, Brown GG, Meloy MJ, Eberson S, Niculescu AB, Lohr JB. Caligiuri MP, et al. Among authors: lohr jb. J Affect Disord. 2006 Apr;91(2-3):235-42. doi: 10.1016/j.jad.2006.01.014. Epub 2006 Feb 24. J Affect Disord. 2006. PMID: 16503055

7

Treatment predictors of extrapyramidal side effects in patients with tardive dyskinesia: results from Veterans Affairs Cooperative Study 394.

Lohr JB, Caligiuri MP, Edson R, Lavori P, Adler LA, Rotrosen J, Hitzemann R. Lohr JB, et al. J Clin Psychopharmacol. 2002 Apr;22(2):196-200. doi: 10.1097/00004714-200204000-00014. J Clin Psychopharmacol. 2002. PMID: 11910266

8

Vitamin E in the treatment of tardive dyskinesia: the possible involvement of free radical mechanisms.

Lohr JB, Cadet JL, Lohr MA, Larson L, Wasli E, Wade L, Hylton R, Vidoni C, Jeste DV, Wyatt RJ. Lohr JB, et al. Among authors: lohr ma. Schizophr Bull. 1988;14(2):291-6. doi: 10.1093/schbul/14.2.291. Schizophr Bull. 1988. PMID: 2904696 Clinical Trial.

9

A potential mechanism underlying the voluntary suppression of tardive dyskinesia.

Caligiuri MP, Lohr JB. Caligiuri MP, et al. Among authors: lohr jb. J Psychiatr Res. 1989;23(3-4):257-66. doi: 10.1016/0022-3956(89)90031-9. J Psychiatr Res. 1989. PMID: 2576826

10

Serum-soluble interleukin-2 receptors in neuroleptic-naive schizophrenic subjects and in medicated schizophrenic subjects with and without tardive dyskinesia.

Rapaport MH, Lohr JB. Rapaport MH, et al. Among authors: lohr jb. Acta Psychiatr Scand. 1994 Nov;90(5):311-5. doi: 10.1111/j.1600-0447.1994.tb01599.x. Acta Psychiatr Scand. 1994. PMID: 7872033 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

149 results

Search Page